BioSpace News Archive

Entera Bio Ltd. (NASDAQ: ENTX), a leader in the development of orally delivered peptides and therapeutic proteins, today announced that Dr. Phillip Schwartz, the Company’s President of Research & Development and Founder, will resign from his current role effective July 21, 2022 to pursue other opportunities.

Lytus Technologies Holdings PTV. Ltd. (NASDAQ: LYT) (the “Company”), a platform technology services company with nearly 8 million users and with operations in the USA and India, today announced the closing of its initial public offering of 2,609,474 common shares at a public offering price of $4.75 per share, for gross proceeds of $12,395,000, before deducting underwriting discounts, commissions and offering expenses.

Syngenta Group announced succession plans for its leadership team. Jeff Rowe, currently President, Global Seeds, will take over the leadership of Syngenta Crop Protection, effective July 1, 2022.

Biomedical refrigerators and freezers are utilized as a part of medicine and biotechnology.

Wilmington, Delaware, United States: The essential types of services provided by the vendors and players functional within the global bioinformatics services market include data analysis, gene expression, sequencing, database management, and discovery, among others.

Wilmington, Delaware, United States: Because of the high frequency of bladder cancer and colorectal cancer, growing number of activities to develop awareness about stoma, rising demand for stoma care and accessories, and technological developments is expected to drive global stoma care market in the near future.

In vitro diagnostics and laboratory developed tests for autoimmune diseases are a key part of the global healthcare sector and are likely to account for a significant share in the same in the coming years due to the rising investment in the healthcare sector from various channels.

Centene Corporation will host its June investor day. During the presentation, the Company will discuss its updated 2022 Premium and Service Revenues and Adjusted Diluted Earnings Per Share guidance and provide updates on its Value Creation Plan.

Quotient Limited (NASDAQ: QTNT), a commercial-stage diagnostics company, today announced that financial results for its fiscal fourth quarter and full year ended March 31, 2022 will be released before market open on Wednesday, June 22, 2022.

Aura Biosciences Inc. (NASDAQ: AURA), a clinical-stage biotechnology company developing a novel class of virus-like drug conjugate (VDC) therapies for multiple oncology indications, today announced multiple presentations of data evaluating its first VDC, belzupacap sarotalocan (AU-011), for the first-line treatment of patients with early-stage choroidal melanoma (indeterminate lesions and small choroidal melanoma (CM)).